Top Story

Simplify Medical closes $21 million Series B financing for trials on cervical artificial disc

August 5, 2017

Simplify Medical Pty Ltd. announced it has closed $21 million Series B financing, which will be used to support clinical trials of a cervical artificial disc, according to a company press release.

Life Science Partners led the round, along with investment from Sectoral Asset Management and M.H. Carnegie, a returning investor. Simplify Medical will use the new funds to complete two, ongoing pivotal clinical trials of the Simplify Disc in the United States. The trials are enrolling patients and will study the use of the disc for one level of the spine and for two adjacent levels for treatment of cervical degenerative disc disease.

In the Journals

Metabolite, functional profile of patients with CSM may be used to discriminate mild, moderate disease

June 30, 2017
Results from this recently published study indicated the N-acetylaspartate to creatine ratio and the volume of activation in the primary motor cortex can be used to…
In the Journals

Similar clinical outcomes seen with hybrid-CDA, ACDF for patients with congenital cervical stenosis

June 22, 2017
Investigators of this study found in patients with myelopathy due to congenital cervical stenosis, hybrid-cervical disc arthroplasty had similar clinical improvements as…
In the JournalsFrom OT Europe

Study explores reliable method to estimate cervical sagittal alignment

June 21, 2017
Investigators of this study found the modified Toyama method was a better technique used for the assessment of the sagittal alignment of the cervical spine. Researchers…
More Headlines »